Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBC.1.6.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.6.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.39NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.39NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.141NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.141NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.141NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.591NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.591NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.591NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.468NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.468NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.468NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.131 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.131 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.131 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.586NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.586NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.586NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.366NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-17007.8US
B.1.366NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.366NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18000.3China
B.1.1.380NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.380NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.380NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.148NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.148NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.148NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.382NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.382NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.382NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.356NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.356NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.356NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.376NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.376NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.376NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.607NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.607NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.607NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.163NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.163NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.163NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.337NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.337NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.337NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.158NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.158NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.158NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used